7AW1
MerTK kinase domain in complex with a type 2 inhibitor
7AW1 の概要
エントリーDOI | 10.2210/pdb7aw1/pdb |
分子名称 | Tyrosine-protein kinase Mer, N-(6-(4-(3-(4-((5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)methyl)-3-(trifluoromethyl)phenyl)ureido)phenoxy)pyrimidin-4-yl)cyclopropanecarboxamide (3 entities in total) |
機能のキーワード | tyrosine kinase, inhibitor, type2 kinase inhibitor, structure-based drug design, high-throughput screening, oncology, signaling protein |
由来する生物種 | Homo sapiens (Human) |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 34974.33 |
構造登録者 | Schimpl, M.,Nissink, J.W.M.,Blackett, C.,Goldberg, K.,Hennessy, E.J.,Hardaker, E.,McCoull, W.,McMurray, L.,Collingwood, O.,Overman, R.,Pflug, A.,Preston, M.,Rawlins, P.,Rivers, E.,Smith, P.,Underwood, E.,Truman, C.,Warwicker, J.,Winter, J.,Woodcock, S. (登録日: 2020-11-06, 公開日: 2021-03-03, 最終更新日: 2024-05-01) |
主引用文献 | Nissink, J.W.M.,Bazzaz, S.,Blackett, C.,Clark, M.A.,Collingwood, O.,Disch, J.S.,Gikunju, D.,Goldberg, K.,Guilinger, J.P.,Hardaker, E.,Hennessy, E.J.,Jetson, R.,Keefe, A.D.,McCoull, W.,McMurray, L.,Olszewski, A.,Overman, R.,Pflug, A.,Preston, M.,Rawlins, P.B.,Rivers, E.,Schimpl, M.,Smith, P.,Truman, C.,Underwood, E.,Warwicker, J.,Winter-Holt, J.,Woodcock, S.,Zhang, Y. Generating Selective Leads for Mer Kinase Inhibitors-Example of a Comprehensive Lead-Generation Strategy. J.Med.Chem., 64:3165-3184, 2021 Cited by PubMed: 33683117DOI: 10.1021/acs.jmedchem.0c01904 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.98 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード